Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study

Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study

Circulating albumin structures, including their oxidized and reduced forms, are involved in hepatic encephalopathy (HE) development. However, the effects of rifaximin, a key drug in HE treatment, on the circulating albumin structure in patients with liver cirrhosis remain unclear. In this multicente...

Full description

Bibliographic Details
Main Authors: Takao Miwa, Tatsunori Hanai, Kenji Imai, Koji Takai, Makoto Shiraki, Hideki Hayashi, Shogo Shimizu, Yoichi Nishigaki, Eiichi Tomita, Masahito Shimizu
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Journal of Clinical Medicine
Subjects:
albumin structure
ammonia
hepatic encephalopathy
oxidative stress
rifaximin
Online Access:https://www.mdpi.com/2077-0383/11/24/7318

Internet

https://www.mdpi.com/2077-0383/11/24/7318

Similar Items